Raymond James & Associates’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-375
Closed -$5.5K 4032
2024
Q1
$5.5K Hold
375
﹤0.01% 3866
2023
Q4
$5.46K Hold
375
﹤0.01% 3758
2023
Q3
$8.94K Hold
375
﹤0.01% 3727
2023
Q2
$4.97K Hold
375
﹤0.01% 3762
2023
Q1
$29.3K Hold
375
﹤0.01% 3725
2022
Q4
$31.2K Buy
375
+125
+50% +$10.4K ﹤0.01% 3688
2022
Q3
$23K Hold
250
﹤0.01% 3723
2022
Q2
$37K Hold
250
﹤0.01% 3755
2022
Q1
$61K Sell
250
-13
-5% -$3.17K ﹤0.01% 3824
2021
Q4
$79K Buy
263
+13
+5% +$3.91K ﹤0.01% 3847
2021
Q3
$103K Sell
250
-25
-9% -$10.3K ﹤0.01% 3787
2021
Q2
$84K Hold
275
﹤0.01% 3806
2021
Q1
$57K Hold
275
﹤0.01% 3760
2020
Q4
$55K Hold
275
﹤0.01% 3554
2020
Q3
$46K Sell
275
-38
-12% -$6.36K ﹤0.01% 3398
2020
Q2
$78K Sell
313
-573
-65% -$143K ﹤0.01% 3283
2020
Q1
$162K Buy
886
+32
+4% +$5.85K ﹤0.01% 3090
2019
Q4
$247K Hold
854
﹤0.01% 3183
2019
Q3
$233K Buy
854
+63
+8% +$17.2K ﹤0.01% 3142
2019
Q2
$298K Sell
791
-63
-7% -$23.7K ﹤0.01% 3001
2019
Q1
$229K Buy
854
+13
+2% +$3.49K ﹤0.01% 3135
2018
Q4
$179K Buy
841
+25
+3% +$5.32K ﹤0.01% 3158
2018
Q3
$366K Buy
816
+416
+104% +$187K ﹤0.01% 2895
2018
Q2
$162K Sell
400
-14
-3% -$5.67K ﹤0.01% 3299
2018
Q1
$226K Buy
414
+186
+82% +$102K ﹤0.01% 3053
2017
Q4
$137K Sell
228
-25
-10% -$15K ﹤0.01% 3126
2017
Q3
$116K Buy
253
+65
+35% +$29.8K ﹤0.01% 3126
2017
Q2
$76K Hold
188
﹤0.01% 3095
2017
Q1
$39K Buy
+188
New +$39K ﹤0.01% 3083
2016
Q4
Sell
-375
Closed -$55K 3183
2016
Q3
$55K Buy
+375
New +$55K ﹤0.01% 3004